1. The Role of Adipokines in Surgical Procedures Requiring Both Liver Regeneration and Vascular Occlusion
   Ana Álvarez-Mercado et al, 2018, International Journal of Molecular Sciences CrossRef
2. The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice
   Pnina Fishman et al, 2019, International Journal of Molecular Medicine CrossRef
3. Addition of Berberine to Preservation Solution in an Animal Model of Ex Vivo Liver Transplant Preserves Mitochondrial Function and Bioenergetics from the Damage Induced by Ischemia/Reperfusion
   Rui Martins et al, 2018, International Journal of Molecular Sciences CrossRef
4. Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
   Ohad Etzion et al, 2024, Biomedicines CrossRef
5. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines
   Jana Kotulova et al, 2022, International Journal of Molecular Medicine CrossRef
6. Drugs targeting adenosine signaling pathways: A current view
   Barbara Kutryb-Zając et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. Pre‐conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion
   Chenxia Hu et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
8. Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities
   Ping Wang et al, 2020, JHEP Reports CrossRef
9. Roquin-1 Regulates Macrophage Immune Response and Participates in Hepatic Ischemia–Reperfusion Injury
   Lei Zheng et al, 2020, The Journal of Immunology CrossRef
10. Ectonucleotidases in Intestinal and Hepatic Inflammation
    Marta Vuerich et al, 2019, Frontiers in Immunology CrossRef
11. Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
    Yajie Fu et al, 2022, Frontiers in Pharmacology CrossRef
12. A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model
    Inbal Itzhak et al, 2022, Andrologia CrossRef
13. Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury
    Shuyuan Yi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
14. Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A3 adenosine receptor in HL-60 cells
    Zhan-Guo Gao et al, 2024, Purinergic Signalling CrossRef
15. Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
    Pnina Fishman et al, 2023, Purinergic Signalling CrossRef
16. Design and in vivo activity of A3 adenosine receptor agonist prodrugs
    R. Rama Suresh et al, 2020, Purinergic Signalling CrossRef
17. A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy
    Kenneth A. Jacobson et al, 2018, Medicinal Research Reviews CrossRef
18. Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity
    Marta Vuerich et al, 2019, International Journal of Molecular Sciences CrossRef
19. Mechanisms and therapeutic targets of ischemic acute kidney injury
    Sang Jun Han et al, 2019, Kidney Research and Clinical Practice CrossRef
20. Effects of propofol combined with remifentanil anesthesia on the NO, endothelin and inflammatory cytokines in the plasma of patients with liver cirrhosis during the perioperative period
    Yongsheng Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
21. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
    Ricardo O. S. Soares et al, 2019, International Journal of Molecular Sciences CrossRef
22. Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
    Rifaat Safadi et al, 2021, Alimentary Pharmacology & Therapeutics CrossRef
23. A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A3 Receptor in Living Cells
    Maria Augusta Arruda et al, 2017, Frontiers in Pharmacology CrossRef